Stay updated on HIV+ Safety of High-dose Rifapentine-Isoniazid DDI Clinical Trial

Sign up to get notified when there's something new on the HIV+ Safety of High-dose Rifapentine-Isoniazid DDI Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the HIV+ Safety of High-dose Rifapentine-Isoniazid DDI Clinical Trial page

  1. Check
    5 days ago
    Change Detected
    Summary
    Version updated from v3.4.2 to v3.4.3. No user-facing content or study details appear to be changed.
    Difference
    0.1%
    Check dated 2026-03-11T17:02:29.000Z thumbnail image
  2. Check
    13 days ago
    No Change Detected
  3. Check
    20 days ago
    No Change Detected
  4. Check
    34 days ago
    Change Detected
    Summary
    Revision: v3.4.2 is now shown; the prior funding-related notice and the v3.4.1 revision have been removed, with no impact on study content. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.4%
    Check dated 2026-02-11T05:41:04.000Z thumbnail image
  5. Check
    41 days ago
    Change Detected
    Summary
    Introduced a government funding update notice and updated the site revision to v3.4.1.
    Difference
    0.4%
    Check dated 2026-02-04T05:20:07.000Z thumbnail image
  6. Check
    48 days ago
    Change Detected
    Summary
    Glossary display added and metadata labels updated, including a new 'Last Update Submitted that Met QC Criteria', a 'No FEAR Act Data' notice, and a new revision tag 'Revision: v3.4.0' that supersedes the previous QC label, FEAR data note, and version v3.3.4. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.2%
    Check dated 2026-01-28T03:51:54.000Z thumbnail image
  7. Check
    62 days ago
    Change Detected
    Summary
    Page revision updated from v3.3.3 to v3.3.4. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.1%
    Check dated 2026-01-14T00:50:30.000Z thumbnail image
  8. Check
    84 days ago
    Change Detected
    Summary
    Added a Location entry for Gauteng, South Africa under Locations and updated the page revision from v3.3.2 to v3.3.3. The Gauteng Locations listing and the HHS Vulnerability Disclosure link were removed.
    Difference
    0.2%
    Check dated 2025-12-23T08:44:56.000Z thumbnail image

Stay in the know with updates to HIV+ Safety of High-dose Rifapentine-Isoniazid DDI Clinical Trial

Enter your email address, and we'll notify you when there's something new on the HIV+ Safety of High-dose Rifapentine-Isoniazid DDI Clinical Trial page.